Nucleic acids encoding antibodies with high affinity for Alpha-Klotho
An antibody and/or binding fragment thereof, wherein the antibody and/or binding fragment thereof specifically binds to an epitope of a αKlotho polypeptide, optionally a folded αKlotho or optionally with a dissociation constant (K D ) of about 2 nM or less, as measured by competitive ELISA assay, methods of making and using to diagnose kidney diseases.
1. A nucleic acid encoding an antibody and/or antigen binding fragment thereof, wherein said antibody and/or antigen binding fragment thereof comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprising complementarity determining regions CDR-L1, CDR-L2 and CDR-L3 and the heavy chain variable region comprising complementarity determining regions CDR-H1, CDR-H2 and CDR-H3, with the amino acid sequences of said CDRs set forth below:
CDR-L1: SEQ ID NO: 9;
CDR-L2: SEQ ID NO: 10;
CDR-L3: SEQ ID NO: 5;
CDR-H1: SEQ ID NO: 6;
CDR-H2: SEQ ID NO: 7; and
CDR-H3: SEQ ID NO: 8.
2. The nucleic acid of claim 1 , wherein the light chain variable region of the antibody and/or antigen binding fragment thereof comprises the amino acid sequence set forth in SEQ ID NO: 11.
3. The nucleic acid of claim 1 , wherein the heavy chain variable region of the antibody and/or antigen binding fragment thereof comprises the amino acid sequence set forth in SEQ ID NO: 12.
4. The nucleic acid of claim 1 , wherein the antibody and/or antigen binding fragment thereof comprises heavy chain IgG1 or IgG4 isotypes, with the amino acid sequence of said isotypes set forth in SEQ ID NO: 13 or SEQ ID NO:14.
5. The nucleic acid of claim 1 , wherein the antibody and/or antigen binding fragment thereof specifically binds to an epitope of an αKlotho polypeptide, said αKlotho polypeptide being soluble αKlotho polypeptide.
6. The nucleic acid of claim 1 , wherein the antibody and/or antigen binding fragment thereof specifically binds to an epitope of an αKlotho polypeptide, said αKlotho polypeptide being mammalian αKlotho polypeptide, optionally human αKlotho polypeptide or rodent αKlotho polypeptide.
7. The nucleic acid of claim 1 , wherein the antibody and/or antigen binding fragment thereof binds soluble αKlotho polypeptide found in urine, plasma, and/or serum.
8. The nucleic acid of claim 1 , wherein the antibody and/or antigen binding fragment thereof binds a complex comprising folded αKlotho polypeptide.
9. A vector comprising the nucleic acid of claim 1 .
10. A recombinant cell comprising the nucleic acid of claim 1 or a vector comprising said nucleic acid.
11. A composition comprising the nucleic acid of claim 1 or a vector comprising said nucleic acid.
12. A composition comprising the recombinant cell of claim 10 .
13. A method for producing an antibody and/or antigen binding fragment thereof with specific binding affinity to an epitope of an αKlotho polypeptide, the steps comprising:
a. expressing in a host cell the nucleic acid according to claim 1 ;
b. culturing the host cell to produce the antibody and/or antigen binding fragment thereof; and
c. isolating and purifying the antibody and/or antigen binding fragment thereof from the host cell.
14. A kit comprising the nucleic acid according to claim 1 or a vector comprising said nucleic acid, a reference agent and optionally instructions for use thereof.